Randomized, Double Blind, Multicenter, Placebo Controlled, Proof of Concept Trial to Assess the Efficacy and Safety of 4 Weeks Treatment With AUS 131 (S Equol) on Benign Prostatic Hyperplasia
Phase of Trial: Phase II
Latest Information Update: 23 May 2017
At a glance
- Drugs AUS 131 (Primary)
- Indications Benign prostatic hyperplasia
- Focus Proof of concept; Therapeutic Use
- Sponsors Ausio Pharmaceuticals
- 07 Jun 2017 Biomarkers information updated
- 08 Jan 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 12 Feb 2015 Planned End Date changed from 1 Feb 2015 to 1 Jun 2016 as reported by ClinicalTrials.gov record.